EIR Wyeth BioPharma Division of Wyeth Pharmaceuticals Jan 2019

Maxwell Van Tassell FDA$595.00 - Available Now

FDA investigators audited the Wyeth BioPharma Division of Wyeth Pharmaceuticals - Andover, MA, United States facility and issued inspectional observation (via FDA 483) on 18 Jan 2019.

Product details

  • Category:
  • Inspection end: 18 Jan 2019
  • Location: Andover, United States
  • FEI: 1222181
Add To Cart